The onset of autoimmunity has been associated with viral infections, and it has been suggested that SARS-CoV-2 could be a triggering factor for the development of a rapid autoimmune, autoinflammatory disease in genetically predisposed individuals as those with high systemic interleukin-6 [28, 29], similar to what has been found in SARS‐CoV, influenza, and dengue infections. The gene discussed is IL6; the disease is viral infectious disease.